Investing.com - Jubilant Pharmova reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Jubilant Pharmova announced earnings per share of ₹0.34 on revenue of ₹16.00. Analysts polled by Investing.com anticipated EPS of ₹9.95 on revenue of ₹15.01B.
Jubilant Pharmova shares are down 42.55% from the beginning of the year and are trading at ₹337.00 , down-from-52-week-high.
Jubilant Pharmova follows other major Healthcare sector earnings this month
Jubilant Pharmova's report follows an earnings missed by Syngene International Ltd on Thursday, October 20, 2022, who reported EPS of ₹2.53 on revenue of ₹7.68B, compared to forecasts EPS of ₹2.65 on revenue of ₹7.21B.
Granules India had beat expectations on Thursday, October 20, 2022 with second quarter EPS of ₹5.82 on revenue of ₹11.51B, compared to forecast for EPS of ₹5.2 on revenue of ₹10.71B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar